Lirum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	45	-	-
Enterprise Value	41	-	-
Debt / Equity Ratio	-	-	-0.26
Debt / EBITDA Ratio	-	-	0.26
Debt / FCF Ratio	-	-	-1.64
Quick Ratio	1.84	1.84	0.10
Interest Coverage	355.84	355.84	188.59
Return on Equity (ROE)	92.09%	92.09%	-99.91%
Return on Assets (ROA)	48.16%	48.16%	468.20%
Return on Capital (ROIC)	-91.83%	-91.83%	134.35%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).